Stockscreener 앱 받기
51.74
2.15%
1.09
시간 외 거래:
51.74
전일 마감가:
$50.65
열려 있는:
$50.58
하루 거래량:
499.10K
Relative Volume:
0.82
시가총액:
$2.16B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-11.15
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+3.54%
1개월 성능:
+18.81%
6개월 성능:
+59.15%
1년 성능:
+42.34%
1일 변동 폭
$49.55
$52.30
1주일 범위
$48.40
$52.63
52주 변동 폭
$20.08
$57.28
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
51.74 | 2.16B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Fastest-Growing Public Cos. Ride Healthcare Boom - Orange County Business Journal
Tarsus Pharmaceuticals CEO sells $300,000 in stock - Investing.com India
Where are the Opportunities in (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock - Investing.com
Tarsus Pharmaceuticals’ general counsel sells $463,765 in stock - Investing.com India
Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock - Investing.com
Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 - Investing.com
Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock - Investing.com
Tarsus Pharmaceuticals’ HR chief sells shares worth $321,323 - Investing.com
Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock - Investing.com
Tarsus Pharmaceuticals Executives Sell Shares to Cover Tax Obligations - TradingView
Tarsus Pharmaceuticals completes $134.8M stock offering By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals completes $134.8M stock offering - Investing.com India
Tarsus prices $125M stock offering - MSN
Tarsus Pharma dips after upsized $125 mln stock offering - TradingView
Tarsus Pharmaceuticals Prices Upsized $125 Million Equity Offering -March 13, 2025 at 03:44 am EDT - Marketscreener.com
Tarsus Pharmaceuticals launches $100 million stock offering - Investing.com Australia
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewswire
Tarsus Secures Massive $125M Capital Raise as Investors Rush Into Upsized Offering - StockTitan
Tarsus Announces Pricing Of Upsized $125 Million Public Offering -March 12, 2025 at 09:50 pm EDT - Marketscreener.com
Tarsus Pharmaceuticals dips on planned $100 million equity raise - TradingView
Tarsus Pharmaceuticals launches $100 million stock offering By Investing.com - Investing.com Canada
Tarsus Announces Proposed $100.0 Million Public Offering - The Manila Times
Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles - Investing.com
Tarsus Pharma: Strong Execution In Xdemvy Commercialization (NASDAQ:TARS) - Seeking Alpha
Oppenheimer & Co. Inc. Takes Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 5.8% Following Analyst Upgrade - Defense World
Contrasting PharmaCyte Biotech (OTCMKTS:PMCBD) & Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World
Tarsus to Participate in Upcoming Investor Conference - GlobeNewswire
Tarsus Pharmaceuticals Inc (TARS) to Participate in Barclays Global Healthcare Conference - GuruFocus.com
Healthcare Spotlight: Tarsus Takes Center Stage at Major Barclays Conference - StockTitan
Tarsus Pharmaceuticals price target raised to $58 from $54 at Jefferies - TipRanks
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
0.34%
자본화:
|
볼륨(24시간):